{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T18:16:59Z","timestamp":1779128219503,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.antiviral.2020.104849","type":"journal-article","created":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T01:25:44Z","timestamp":1592097944000},"page":"104849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["In vitro inhibition of mumps virus replication by favipiravir (T-705)"],"prefix":"10.1016","volume":"180","author":[{"given":"Benton","family":"Lawson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suganthi","family":"Suppiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Rota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4047-8151","authenticated-orcid":false,"given":"Carole J.","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald R.","family":"Latner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.antiviral.2020.104849_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00487-17","article-title":"Understanding the mechanism of the broad-spectrum antiviral activity of favipiravir (T-705): key role of the F1 motif of the viral polymerase","volume":"91","author":"Abdelnabi","year":"2017","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104849_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jmv.10392","article-title":"Identification of a new genotype H wild-type mumps virus strain and its molecular relatedness to other virulent and attenuated strains","volume":"70","author":"Amexis","year":"2003","journal-title":"J. Med. Virol."},{"issue":"44","key":"10.1016\/j.antiviral.2020.104849_bib3","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1016\/j.vaccine.2009.06.109","article-title":"Mumps resurgences in the United States: a historical perspective on unexpected elements","volume":"27","author":"Barskey","year":"2009","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.antiviral.2020.104849_bib4","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1128\/JCM.00614-07","article-title":"Real-time reverse transcription-PCR assay for detection of mumps virus RNA in clinical specimens","volume":"45","author":"Boddicker","year":"2007","journal-title":"J. Clin. Microbiol."},{"issue":"38","key":"10.1016\/j.antiviral.2020.104849_bib5","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1016\/j.vaccine.2018.08.028","article-title":"Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China","volume":"36","author":"Cui","year":"2018","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.antiviral.2020.104849_bib6","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral","volume":"69","author":"Delang","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2020.104849_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2018.03.003","article-title":"Favipiravir as a potential countermeasure against neglected and emerging RNA viruses","volume":"153","author":"Delang","year":"2018","journal-title":"Antivir. Res."},{"issue":"7","key":"10.1016\/j.antiviral.2020.104849_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104849_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5365\/wpsar.2017.8.4.002","article-title":"Epidemiology of vaccine-preventable diseases in Japan: considerations for pre-travel advice for the 2019 rugby world cup and 2020 summer olympic and paralympic games. Western pacific surveillance and response","volume":"9","author":"Griffith","year":"2018","journal-title":"J. WPSAR"},{"issue":"40","key":"10.1016\/j.antiviral.2020.104849_bib10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.15585\/mmwr.mm6740a4","article-title":"Vaccination coverage among children aged 19-35 Months - United States, 2017","volume":"67","author":"Hill","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2020.104849_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.antiviral.2017.06.011","article-title":"4'-Azidocytidine (R1479) inhibits henipaviruses and other paramyxoviruses with high potency","volume":"144","author":"Hotard","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104849_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2019.04.002","article-title":"Cell line-dependent activation and antiviral activity of T-1105, the non-fluorinated analogue of T-705 (favipiravir)","volume":"167","author":"Huchting","year":"2019","journal-title":"Antivir. Res."},{"issue":"8","key":"10.1016\/j.antiviral.2020.104849_bib13","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1128\/AAC.00709-16","article-title":"Antiviral activity of favipiravir (T-705) against a broad range of paramyxoviruses in vitro and against human metapneumovirus in hamsters","volume":"60","author":"Jochmans","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.antiviral.2020.104849_bib14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1442-200x.2004.01968.x","article-title":"Complementary findings in clinical and epidemiologic features of mumps and mumps meningoencephalitis in children without mumps vaccination","volume":"46","author":"Kanra","year":"2004","journal-title":"Pediatr. Int."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104849_bib15","doi-asserted-by":"crossref","first-page":"ofx263","DOI":"10.1093\/ofid\/ofx263","article-title":"Mumps virus nucleoprotein and hemagglutinin-specific antibody response following a third dose of measles mumps rubella vaccine","volume":"4","author":"Latner","year":"2017","journal-title":"Open forum infectious diseases"},{"issue":"4","key":"10.1016\/j.antiviral.2020.104849_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1086\/596207","article-title":"Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine","volume":"199","author":"LeBaron","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104849_bib17","doi-asserted-by":"crossref","first-page":"43395","DOI":"10.1038\/srep43395","article-title":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses","volume":"7","author":"Lo","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104849_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnen\/nlz117","article-title":"Chronic hydrocephalus following mumps encephalitis: neuropathological correlates and review","volume":"79","author":"MacRae","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.antiviral.2020.104849_bib19","doi-asserted-by":"crossref","first-page":"26742","DOI":"10.1038\/srep26742","article-title":"Combinations of oseltamivir and T-705 extend the treatment window for highly pathogenic influenza A(H5N1) virus infection in mice","volume":"6","author":"Marathe","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104849_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.15585\/mmwr.mm6701a7","article-title":"Recommendation of the advisory committee on immunization practices for use of a third dose of mumps virus-containing vaccine in persons at increased risk for mumps during an outbreak","volume":"67","author":"Marin","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2020.104849_bib21","first-page":"1","article-title":"Universities' experience with mumps outbreak response and use of a third dose of MMR vaccine","author":"Marlow","year":"2019","journal-title":"J. Am. Coll. Health"},{"issue":"3","key":"10.1016\/j.antiviral.2020.104849_bib22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/AAC.15.3.356","article-title":"Effects of ribavirin on BHK-21 cells acutely or persistently infected with mumps virus","volume":"15","author":"McCammon","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104849_bib23","series-title":"The Immunological Basis for Immunization Series, Module 16: Mumps","first-page":"44","author":"McLean","year":"2010"},{"issue":"3","key":"10.1016\/j.antiviral.2020.104849_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.antiviral.2008.07.009","article-title":"Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents","volume":"80","author":"Morrey","year":"2008","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104849_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005389","article-title":"Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted","volume":"11","author":"Nguyen","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104849_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3947\/ic.2015.47.1.1","article-title":"Resurgence of mumps in korea","volume":"47","author":"Park","year":"2015","journal-title":"Infection & chemotherapy"},{"issue":"10095","key":"10.1016\/j.antiviral.2020.104849_bib27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(17)30129-0","volume":"390","author":"Paules","year":"2017","journal-title":"Influenza. Lancet."},{"issue":"8","key":"10.1016\/j.antiviral.2020.104849_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073014","article-title":"Persistent infection of human fetal endothelial cells with rubella virus","volume":"8","author":"Perelygina","year":"2013","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.antiviral.2020.104849_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174444","article-title":"Establishing a small animal model for evaluating protective immunity against mumps virus","volume":"12","author":"Pickar","year":"2017","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.antiviral.2020.104849_bib30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1128\/CVI.00660-12","article-title":"Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009","volume":"20","author":"Rota","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104849_bib31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1086\/590115","article-title":"Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak","volume":"198","author":"Rubin","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.antiviral.2020.104849_bib32","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/pr.2015.141","article-title":"Virus genotypes and responses of serum-specific antibodies in children with primary mumps and mumps reinfection","volume":"78","author":"Sakata","year":"2015","journal-title":"Pediatr. Res."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104849_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001967","article-title":"Experimental treatment with favipiravir for ebola virus disease (the jiki trial): a historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med."},{"issue":"7","key":"10.1016\/j.antiviral.2020.104849_bib34","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/cid\/civ531","article-title":"Time from infection to disease and infectiousness for ebola virus disease, a systematic review","volume":"61","author":"Velasquez","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104849_bib35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ncl.2018.07.001","article-title":"Viral encephalitis","volume":"36","author":"Venkatesan","year":"2018","journal-title":"Neurol. Clin."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104849_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/0883073812441060","article-title":"Mumps virus-associated acute encephalopathy: case report and review of the literature","volume":"28","author":"Watanabe","year":"2013","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.antiviral.2020.104849_bib37","year":"2019"},{"issue":"1","key":"10.1016\/j.antiviral.2020.104849_bib38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.virol.2011.05.003","article-title":"Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to define the role of the SH ORF in the pathogenesis of mumps virus","volume":"417","author":"Xu","year":"2011","journal-title":"Virology"},{"issue":"14","key":"10.1016\/j.antiviral.2020.104849_bib39","doi-asserted-by":"crossref","first-page":"8158","DOI":"10.1128\/JVI.01028-13","article-title":"Infection of mice, ferrets, and rhesus macaques with a clinical mumps virus isolate","volume":"87","author":"Xu","year":"2013","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.antiviral.2020.104849_bib40","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1080\/21645515.2015.1021522","article-title":"Characteristics of a large mumps outbreak: clinical severity, complications and association with vaccination status of mumps outbreak cases","volume":"11","author":"Zamir","year":"2015","journal-title":"Hum. Vaccines Immunother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:32:25Z","timestamp":1759062745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220302631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":40,"alternative-id":["S0166354220302631"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104849","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro inhibition of mumps virus replication by favipiravir (T-705)","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104849"}}